A Final Rule Bites the Dust, Part II: FDA Gives up on Regulating LDTs as Medical Devices

Start
As the song goes, the Food and Drug Administration’s (“FDA’s”) 2024 Final Rule regulating laboratory-developed tests (“LDTs”) as medical devices (“Final Rule”), is not merely dead—it’s really most sincerely dead….
By: Epstein Becker & Green
Previous Story

US, Australian, New Zealand and UK cybersecurity agencies publish guidance on best practices for securing data used to train and operate AI systems

Next Story

The Evaluator Industry Spotlight: Data Centers